Background Data-sharing mandates from funders and journals have increased in recent years, but little is known about how shared data are used. Existing research has focused on access frameworks, with ...
He is the lead principal investigator of the ALLEGORY study and the lead author and he has also presented the results last Friday at SLEuro. Today, Dr. Richard Furie will take us again through the ...
Anthropic CEO Dario Amodei sat down with CBS News for an exclusive interview Friday, hours after Defense Secretary Pete Hegseth declared the company a supply chain risk to national security, which ...
In this video podcast, EEWorld interviews Supplyframe’s Eric Rimkeit, where he explains the DRAM shortage and a capacitor surplus. Engineers: Work with your procurement team to minimize supply ...
Q4 2025 Earnings Call March 17, 2026 8:00 AM EDTCompany ParticipantsXin WangDagang Feng - Chairman & CEOXiang Li - CFO ...
Elections: The voting technology company Smartmatic asked a federal judge on Tuesday to dismiss the federal criminal charges ...
Background Internationally, investment in hospital-based services for sexual violence is increasing. However, service ...
Roberto Mina, MD, details how in the MajesTEC-9 trial, teclistamab monotherapy boosted PFS and OS in relapsed/refractory multiple myeloma, challenging standardized care.
Although English is widely recognized as a global language, hiring practices in English Language Teaching (ELT) often continue to privilege native-speaker status. This qualitative study explores how ...
The following is the transcript of the interview with Christine Lagarde, European Central Bank president, that aired on "Face the Nation with Margaret Brennan" on Feb. 22, 2026. MARGARET BRENNAN: ...
The great white sharks of False Bay – once so abundant that film crews from around the world came to document them, have all ...
Pembrolizumab plus weekly paclitaxel, with investigator-choice bevacizumab, achieved statistically significant PFS and OS improvements, addressing a high unmet need in platinum-resistant ovarian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results